future glp 1 drugs Heart benefits are erased if patients stop taking GLP-1 medications, a large new study finds. https://cnn.it/4772ftO Beyond GLP-1: the next wave

With a lower list price, the rebate tradeoffs tied to those strategies may be smaller, which may change the cost-benefit balance for some plan sponsors and open the door to additional strategies

For example, methods involving intravenous administration of glutathione are generally not practical for increasing circulating glutathione for most individuals because this procedure is expensive, requires regular visits to a medical practitioner's office, is unsuitable for children and many adults, and poses the risks of side effects associated with regular injections

While glutathione is the master of the liver, astaxanthin is often considered the king of the cell membrane

Koji oblik L-karnitina je najefikasniji

Recent research findings and regulatory warnings highlight risks that potential users should carefully consider before pursuing treatment

In order to improve the medication compliance of diabetic patients, polylactic-co-glycolic acid (PLGA) was used to wrap exenatide drug, which has sustained-release effect, and the half-life is as long as 5-6 days